The Lynx Group

Former US Health & Human Services Administrator John O’Brien Set to Speak at Cancer Care Stakeholders’ Summit

Press Releases — September 6, 2019

CRANBURY, New Jersey, September 9, 2019—The Association for Value-Based Cancer Care (AVBCC) is delighted to announce that John O’Brien, PharmD, MPH, former Senior Advisor to the Secretary, US Department of Health & Human Services (HHS), will present a Summit Keynote speech and Q&A at the 2019 AVBCC Summit on Thursday, October 17, in New York City. The AVBCC Summit is the premier gathering of practitioners, pharmacists, payers, policymakers, and other stakeholders from across the cancer care spectrum. The multiday professional conference is held annually and will return this year to the historic New York Athletic Club in Manhattan, October 16-18

Dr O’Brien was the Senior Advisor to Secretary Alex Azar for Drug Pricing Reform, where he led policy development on multiple administration priorities, including drafting and executing President Trump’s drug pricing blueprint. He also served as Deputy Assistant Secretary for Health Policy, and a key advisor to the Secretary for Health Policy Research, Development, and Analysis related to Medicare, Medicaid, and private health insurance. Previously, Dr O’Brien had served as Advisor to the Secretary for health reform and drug pricing, as well as Deputy Assistant Secretary for Health Policy within the Office of the Assistant Secretary for Planning and Evaluation

Prior to joining HHS, Dr O’Brien held senior policy positions in the life sciences and managed care industries, was a career official at the Centers for Medicare & Medicaid Services during the Obama administration, and served as a Health Policy Fellow in the US Senate. He has a master’s degree in public health from the Johns Hopkins Bloomberg School of Public Health, a doctoral degree in pharmacy from Nova Southeastern University, and studied pharmacy and public policy at the University of Florida

This will be his first speaking appearance since leaving the administration in August. “We are incredibly excited to bring John to the Summit for his first post-government speaking engagement,” said AVBCC Founder and Co-Chair Burt Zweigenhaft. “He was an integral part of HHS’s efforts to bring down the high price of prescription drugs, and I’m certain his remarks will be invaluable for our Summit attendees.” Zweigenhaft continued

For the past 9 years, the AVBCC Summit has brought together nationally recognized experts, faculty speakers, panelists, key opinion leaders, C-suite executives, and managers whose goals are to improve patient care and maximize patient access and outcomes through care coordination. The AVBCC Summit will also feature a keynote presentation by Scott Gottlieb, MD, Former FDA Commissioner. With the addition of Dr O’Brien to the program, Zweigenhaft stated, “we have locked down 2 of the key architects of the current landscape in cancer care.

O’Brien’s and Gottlieb’s sessions will be among the highlights anticipated during the 3 full days of planned workshops, panel discussions, sponsored knowledge exchanges, and impromptu conversations. Other scheduled speakers will be announced. More information about the full agenda, presenters, and registration is available on the AVBCC Summit home page.

AVBCC was established nearly a decade ago to provide a network for payers and oncology healthcare professionals to interact and exchange knowledge to promote optimal care for patients and their families. It currently consists of more than 450 members and is the fastest growing national specialty organization dedicated to improving the care of cancer patients and their quality of life, by discussing, considering, and assessing the value equation as it relates to new and existing cancer therapies.

Amplity Health proudly serves as co-founder and association management company of the Academy of Oncology Nurse & Patient Navigators (AONN+) and the Association for Value-Based Cancer Care (AVBCC).

The true partner of global healthcare companies, Amplity Health continually challenges the boundaries of medical and commercial strategies to accelerate the approval and launch of new drugs to improve the lives of patients. We are proud of our inclusive culture and our EPIIC values. Amplity has the expertise, global infrastructure, and data-driven insights to help clients overcome their medical and commercial challenges.

Amplity’s wide-ranging capabilities include clinical and medical outsourced teams; clinical and medical capability development; companion diagnostic and precision medicine solutions; medical communications; expert engagement; remote and field solutions for patients, payers, and physicians; and strategic and access consulting. Amplity’s one-of-a-kind Insights database offers clients a detailed view into patient–provider interactions and provider treatment rationale not found through any other provider.

For more information, visit amplity.com. Connect with Amplity on Twitter and LinkedIn.

Amplity Health is a portfolio company of Altamont Capital Partners.

Related Articles


Subscribe Today!

To sign up for our newsletter or print publications, please enter your contact information below.

I'd like to receive: